Related Experiment Videos
[Is there a prognostic indication for PTCA?]
M P Heintzen1, C J Michel, U E Heidland
1Medizinische Klinik und Poliklinik B Kardiologie, Pneumologie und Angiologie Heinrich-Heine-Universität, Düsseldorf.
Insights
Percutaneous coronary intervention (PCI) is typically for symptomatic patients with ischemia. For asymptomatic patients, "prognostic indication" for PCI lacks large-scale evidence, requiring careful risk assessment.
Area of Science:
- Cardiology
- Interventional Cardiology
- Clinical Medicine
Background:
- Coronary angioplasty is indicated for symptomatic patients with significant coronary stenosis and myocardial ischemia.
- Percutaneous Transluminal Coronary Angioplasty (PTCA) aims to alleviate symptoms and improve prognosis in these patients.
- Coronary anatomy suitability is crucial for successful PTCA.
Purpose of the Study:
- To define and evaluate the concept of "prognostic indication" for coronary angioplasty in asymptomatic patients.
- To assess the current evidence and clinical considerations for using PTCA in asymptomatic individuals without proven ischemia.
- To highlight the need for risk-benefit analysis in "prognostic indication" cases.
Main Methods:
- Review of current clinical practice and literature regarding coronary angioplasty indications.
- Analysis of the definition and application of "prognostic indication" in interventional cardiology.
- Discussion of the evidence gap for PTCA in asymptomatic patients without ischemia.
Main Results:
- "Prognostic indication" refers to interventional treatment of stenosis in asymptomatic patients without ischemia, aiming to improve prognosis.
- Up to 20% of balloon angioplasty and 10% of stenting procedures may be performed under "prognostic indication".
- No large-scale studies currently demonstrate a benefit of "prognostic indication" interventions in asymptomatic patients without ischemia.
Conclusions:
- While "prognostic indication" is used, robust evidence supporting its benefit in asymptomatic patients without ischemia is lacking.
- Certain subgroups might benefit from PTCA under "prognostic indication" compared to medical therapy alone.
- Careful consideration of individual coronary disease risk versus procedural risk is essential for patients treated with "prognostic indication".
Abstract:
Coronary angioplasty is classically indicated to remove a high grade stenosis of a major coronary vessel supplying a large myocardial territory in a symptomatic patient with proven myocardial ischemia. The coronary anatomy has to be suitable for PTCA to ensure a high success rate for the procedure. PTCA is performed to remove symptoms and myocardial ischemia to improve the prognosis of the patient. In contrast to this, the term "prognostic indication" describes an interventional approach to an angiographically documented high grade stenosis in an asymptomatic patient without proven myocardial ischemia thereby hoping to improve the prognosis of this patient. It has to be expected, that up to 20% of all patients treated by balloon angioplasty and 10% of all stented patients are treated with respect to a "prognostic indication". Until now, there are no statistically significant large-scale studies supporting a benefit of an interventional therapy performed with a "prognostic indication" in asymptomatic patients without ischemia. Nevertheless, some certain subgroups of patients may be candidates for a "prognostic indication" to angioplasty compared to the results of medical therapy. In patients treated interventionally for a "prognostic indication" the acute and long-term individual risk of the underlying coronary disease must be carefully weighted against the risk of the interventional procedure.